Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Price:
999 999.9999 JPY
Market Closed
Updated:
May 14, 2024
Taisho Pharmaceutical Holdings Co Ltd
Interest Income Expense
|
Taisho Pharmaceutical Holdings Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
Interest Income Expense
¥5.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥164.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥11.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-19%
|
See Also
What is Taisho Pharmaceutical Holdings Co Ltd's Interest Income Expense?
Interest Income Expense
5.8B
JPY
5.8B
JPY
Based on the financial report for Dec 31, 2023, Taisho Pharmaceutical Holdings Co Ltd's Interest Income Expense amounts to 5.8B JPY.
What is Taisho Pharmaceutical Holdings Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-4%
-4%
Over the last year, the Interest Income Expense growth was -37%. The average annual Interest Income Expense growth rates for Taisho Pharmaceutical Holdings Co Ltd have been 19% over the past three years , -5% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
